Cancer, musculoskeletal, and neurologic pain
For this analysis, the researchers identified 1.8 million patients in Denmark who were diagnosed with chronic pain between 2018 and 2021.
Of those, around 5,000 patients had claimed at least one prescription of medicinal cannabis (dronabinol 29%, cannabinoids 46%, or cannabidiol 25%).
The patients had a median age of 60 years, and 63% were women.
The cannabis users had been prescribed this therapy for musculoskeletal (35%), cancer (18%), neurological (14%), or other (33%) pain, Dr. Nouhravesh said.
The researchers and Dr. Olshansky have no relevant financial disclosures.
A version of this article first appeared on Medscape.com.